Completed
ORCAEvaluation of Patients' Satisfaction With the Dispensation of Their Oral Anticancer Treatment in Community Pharmacy: Observational and Transversal Study
What is being collected
Data Collection
Collected from today forward - ProspectiveWho is being recruted
Behavior
+ Neoplasms
+ Personal Satisfaction
Over 18 Years
+5 Eligibility Criteria
How is the trial designed
Other
Utilizing specific methods not covered by standard models in order to address unique research questions.Observational
Study Start: June 2017
Summary
Principal SponsorUniversity Hospital, Clermont-Ferrand
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner
Study start date: June 20, 2017
Actual date on which the first participant was enrolled.This observational and transversal study will be conducted as a survey by contacting each eligible patients after complete information by the oncologist. After acceptance, the patients will received a postal mail with the questionnaire and a stamped envelope for the return of completed questionnaire. All the completed questionnaires will be recorded in a specific REDCap database for analysis.
Official TitleEvaluation of Patients' Satisfaction With the Dispensation of Their Oral Anticancer Treatment in Community Pharmacy: Observational and Transversal Study
Principal SponsorUniversity Hospital, Clermont-Ferrand
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
104 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other
Some studies use unique or mixed approaches that don't fit standard categories. These may include innovative observational methods or studies tailored to specific research questions.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
BehaviorNeoplasmsPersonal Satisfaction
Criteria
2 inclusion criteria required to participate
Patient (or helping people) receiving oral cancer chemotherapy or oral hormone therapy delivered in community pharmacy for the treatment of cancer
Non-opposition to participation in the study
3 exclusion criteria prevent from participating
Patient unable to understand or respond to questionnaires
Age < 18
Legal incapacity (person deprived of liberty or under guardianship)
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Suspended
CompletedOne Study Center